Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/29/20
End: 03/16/22
Due: 03/16/23
Phase: N/A
Priority: Normal
Start: 01/11/22
End: 05/17/23
Due: 05/17/24
Phase: N/A
Priority: Normal
Start: 08/30/18
End: 08/25/20
Due: 08/25/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica | NCT04492618 | Aaron R. Mangold | user2@example.com | None | 2020-09-29 | 2022-03-16 | 2023-03-16 | - | - | 2025-07-14 |
| Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus | NCT05188521 | Aaron R. Mangold | user2@example.com | None | 2022-01-11 | 2023-05-17 | 2024-05-17 | - | - | 2025-07-14 |
| Topical Ruxolitinib Lichen Planus | NCT03697460 | Aaron R. Mangold | user2@example.com | None | 2018-08-30 | 2020-08-25 | 2021-08-25 | - | - | 2025-07-14 |